DataMeds AI Advances Corexa Pharmacy with GLP-1 Expansion and App Launch
Aug 12, 2026, 7:43 AM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The update includes a tangible revenue milestone, a cleared path for GLP-1 access expansion, a public app launch in September, and NFL marketing support—all potential near-term catalysts for user adoption, prescriptions, and ancillary sales. While execution and regulatory factors remain, the combination of rebranding, new channels, and a scalable telemedicine model provides a plausible path to accelerating growth and improving valuation in the next 3–6 months.
AI summary
What happened, with direct paths to the underlying reporting
DataMeds AI updates Corexa Health's pharmacy division, now Corexa Pharmacy, with GLP-1 drug access and the Health Lives Here app. July revenue topped $600k, stabilizing a run rate above $7M as the public app launch approaches in September and a North Carolina rollout begins, boosted by NFL Alumni Health marketing.
TrumpRx enables access to oral GLP-1 drugs at $149. Injectables now available.
CorexaRx online store launched; Health Lives Here app integration completed.
Forzet and Tollovid available; expanding nutraceuticals.
July 2026 revenue exceeded $600k; run rate above $7M annually. NFL Alumni Health marketing to drive prescriptions.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
